Health Condition 1: F330- Major depressive disorder, recurrent, mild
Conditions
Interventions
Intervention1: DEKSEL: Cholicalciferol OR VITAMIN-D3 60000IU/5ml
Control Intervention1: PLACEBO: Plain syrup OF 5ml
Sponsors
Pulse Pharmaceuticals Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients suffering from mild to severe depression. 2.18â??65 Years of age, of either gender. 3.Willing to give signed Informed Consent.
Exclusion criteria
Exclusion criteria: 1.Patients suffering from bipolar affective disorder, any form of schizophrenia, tuberculosis, and sarcoidosis. 2.Pregnant or lactating women. 3.Intake of more than 10 μg vitamin D daily. 4.Known allergy, intolerance or contraindication to study medication. 5.Women of childbearing potential not willing to utilize effective contraception. A negative human chorionic gonadotropin (HCG) pregnancy test is required. 6. Patients were excluded if they at baseline had: serum 25(OH)D 100 nmol/L, serum calcium (ionized) >1.40 mmol/L, estimated glomerular filtration rate (eGFR) 49 years), or serum parathyroid hormone (PTH) >9.2 pmol/L.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be assessed using HAM-D17 and MADRSTimepoint: At baseline, 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Clinicians Global Impressions (CGI) Score 2.Incidence of adverse events. Timepoint: 90 DAYS | — |
Countries
India
Contacts
Public ContactDr G Prasad Rao
ASHA HOSPITAL
Outcome results
None listed